Literature DB >> 19293314

A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.

Tian Tian1, Yongqian Shu, Jiaping Chen, Zhibin Hu, Lin Xu, Guangfu Jin, Jie Liang, Ping Liu, Xiaoyi Zhou, Ruifen Miao, Hongxia Ma, Yijiang Chen, Hongbing Shen.   

Abstract

microRNAs (miRNA) are a new class of non-protein-coding, small RNAs that function as tumor suppressors or oncogenes. They participate in diverse biological pathways and function as gene regulators. Recently, we conducted a survey of common single nucleotide polymorphisms (SNP) in miRNA sequences and reported that, among four SNPs (rs2910164, rs2292832, rs11614913, and rs3746444) in pre-miRNAs, rs11614913 in miR-196a2 might affect mature miR-196a expression and target mRNA-binding activity and was significantly associated with non-small cell lung cancer survival. However, it remains largely unknown whether miRNA SNPs may alter lung cancer susceptibility. In the current study, we evaluated associations between the above four SNPs in pre-miRNAs and lung cancer susceptibility in a case-control study of 1,058 incident lung cancer patients and 1,035 cancer-free controls in a Chinese population. We found that miR-196a2 rs11614913 variant homozygote CC was associated with approximately 25% significantly increased risk of lung cancer compared with their wild-type homozygote TT and heterozygote TC (odds ratio, 1.25; 95% confidence interval, 1.01-1.54). However, no significant effects were observed on the association between the other three SNPs and lung cancer risk. These findings suggest that functional SNP rs11614913 in miR-196a2 could also contribute to lung cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293314     DOI: 10.1158/1055-9965.EPI-08-0814

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  138 in total

1.  Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease.

Authors:  Hong Zhi; Lina Wang; Genshan Ma; Xingzhou Ye; Xiaojin Yu; Yi Zhu; Yu Zhang; Jiaju Zhang; Bei Wang
Journal:  Clin Res Cardiol       Date:  2011-12-11       Impact factor: 5.460

2.  Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies.

Authors:  Jun Wang; Jingwang Bi; Xin Liu; Kainan Li; Jianshi Di; Baocheng Wang
Journal:  Mol Biol Rep       Date:  2011-09-24       Impact factor: 2.316

3.  Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls.

Authors:  Jian Zhang; Yan-Fei Liu; Yu Gan
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

Review 4.  Cross talk between microRNA and coding cancer genes.

Authors:  Tanja Kunej; Irena Godnic; Simon Horvat; Minja Zorc; George A Calin
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

5.  Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.

Authors:  Brock C Christensen; Michele Avissar-Whiting; Lauren G Ouellet; Rondi A Butler; Heather H Nelson; Michael D McClean; Carmen J Marsit; Karl T Kelsey
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

Review 6.  MicroRNAs in inflammatory bowel disease.

Authors:  Joel R Pekow; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2011-03-18       Impact factor: 5.325

7.  Association between miR-146aG>C and miR-196a2C>T polymorphisms and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Bing Zhou; Liang-Peng Dong; Xiao-Yue Jing; Jin-Song Li; Shu-Juan Yang; Jun-Ping Wang; Long-Feng Zhao
Journal:  Tumour Biol       Date:  2014-05-10

Review 8.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 9.  MicroRNA in rectal cancer.

Authors:  Azadeh Azizian; Jens Gruber; B Michael Ghadimi; Jochen Gaedcke
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

10.  MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.

Authors:  Guang Yang; Dayong Han; Xin Chen; Daming Zhang; Lu Wang; Chen Shi; Weiguang Zhang; Chenguang Li; Xiaofeng Chen; Huailei Liu; Dongzhi Zhang; Jianhao Kang; Fei Peng; Ziyi Liu; Jiping Qi; Xin Gao; Jing Ai; Changbin Shi; Shiguang Zhao
Journal:  Neuro Oncol       Date:  2014-01-23       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.